Clinical
RSSArticles
-
Antiplatelet Therapy After TAVR: More ARTE Than Science
The current clinical standard of dual antiplatelet therapy following transcatheter aortic valve replacement is controversial.
-
Late-breaking Clinical Trials from the Heart Rhythm Society May 2017 Scientific Sessions
Late-breaking findings of several important clinical trials were presented at this year’s Heart Rhythm Society Scientific Sessions in Chicago. A selection particularly relevant to the general cardiology community is presented here.
-
Are There Definitive Clues?
How certain are you that the run of wide complex tachycardia that begins with beat #4 is ventricular tachycardia?
-
Encephalitis Due to Powassan Virus
Powassan virus is transmitted by the same tick that carries the etiologic agent of Lyme disease and several other pathogens. The number of cases of encephalitis caused by this virus may be increasing in the endemic areas.
-
Ready for Dengue in the United States?
Dengue is increasingly recognized in the southern United States. When recently surveyed, however, clinicians in Texas seemed incompletely prepared to understand and manage patients with dengue.
-
Infective Endocarditis Trends and Outcomes
Using large databases from New York and California, investigators found the overall incidence of infective endocarditis remained stable between 1998 and 2013, and 90-day mortality declined. Changes were noted in pathogen etiology and patient characteristics over time.
-
Clinical Briefs
In this section: Effects of weight gain on the cardiovascular system; comparing sleep apnea treatments; and rhabdomyolysis brought on by exercise.
-
Edaravone Injection (Radicava)
The FDA has approved edaravone, the first new treatment for amyotrophic lateral sclerosis since the approval of riluzole more than 20 years ago.
-
Guillain-Barré Syndrome and Hepatitis E
Hepatitis E is the most common form of viral hepatitis worldwide and often is asymptomatic, but it is commonly associated with Guillain-Barré syndrome and Guillain-Barré variants.
-
Treatment of Chronic Fatigue/Myalgic Encephalitis Syndrome
Blockade of IL-1 activity with anakinra failed to reduce fatigue in patients with chronic fatigue syndrome.